Polaris Group (6550.TW)

TWD 37.5

(-3.72%)

Inventory Summary of Polaris Group

  • Polaris Group's latest annual inventory in 2023 was 36.35 Million TWD , down 0.0% from previous year.
  • Polaris Group's latest quarterly inventory in 2024 Q2 was 45.85 Million TWD , up 14.51% from previous quarter.
  • Polaris Group reported annual inventory of - TWD in 2022, down 0.0% from previous year.
  • Polaris Group reported annual inventory of - TWD in 2021, down 0.0% from previous year.
  • Polaris Group reported quarterly inventory of 40.04 Million TWD for 2024 Q1, up 10.14% from previous quarter.
  • Polaris Group reported quarterly inventory of 36.35 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Polaris Group (2023 - 2016)

Historical Annual Inventory of Polaris Group (2023 - 2016)

Year Inventory Inventory Growth
2023 36.35 Million TWD 0.0%
2022 - TWD 0.0%
2021 - TWD 0.0%
2020 - TWD 0.0%
2019 - TWD 0.0%
2018 - TWD 0.0%
2017 - TWD 0.0%
2016 - TWD 0.0%

Peer Inventory Comparison of Polaris Group

Name Inventory Inventory Difference
Apex Biotechnology Corp. 747.71 Million TWD 95.138%
Sinphar Pharmaceutical Co.,Ltd. 839.19 Million TWD 95.668%
Panion & Bf Biotech Inc. 538.09 Million TWD 93.244%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.21 Billion TWD 96.998%
GenMont Biotech Incorporation 88.11 Million TWD 58.743%
Abnova (Taiwan) Corporation 408.3 Million TWD 91.096%
Adimmune Corporation 526.4 Million TWD 93.094%
Tanvex BioPharma, Inc. 108.28 Million TWD 66.427%
Energenesis Biomedical CO.,LTD. 733 Thousand TWD -4859.754%
UnicoCell Biomed Co., Ltd. 5.45 Million TWD -566.942%
PELL Bio-Med Technology Co. Ltd. 3.76 Million TWD -866.117%